Jameson 2010.
Study characteristics | ||
Methods |
Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial Patient RCT, conducted in 13 primary care offices, USA Two arms: 1. Control (control arm) and 2. Intervention (intervention arm) |
|
Participants | Control arm N: 52 Intervention arm N: 52 Diabetes type: type 1 and type 2 Mean age: 49.5 ± 10.9 % Male: 49.0 Longest follow‐up: 12 months |
|
Interventions |
Control arm: None Intervention arm: 1) Case management 2) Team changes 3) Patient education 4) Promotion of self‐management |
|
Outcomes | 1) HbA1c, mean % (SD) Control arm: pre 11.1 (1.6), post 10.7 (NR) Intervention arm: pre 10.4 (1.2), post 8.9 (NR) |
|
Funding source | Financial support for this study was provided by Advantage Health Physician Network, Doran Foundation, Michigan Pharmacist Foundation, Priority Health, and Western Michigan Society of Health System Pharmacists | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Information not available. |
Allocation concealment (selection bias) | Unclear risk | Information not available. |
Patient's baseline characteristics (selection bias) | Low risk | Information not available. |
Patient's baseline outcomes (selection bias) | High risk | Information not available. |
Incomplete outcome data (attrition bias) | Low risk | Information not available. |
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias) | Low risk | Information not available. |
Selective reporting (reporting bias) | Low risk | Information not available. |
Risk of contamination (other bias) | Low risk | Information not available. |
Other bias | Low risk | Information not available. |